메뉴 건너뛰기




Volumn 28, Issue 27, 2016, Pages 5447-5469

Delivering Nucleic-Acid Based Nanomedicines on Biomaterial Scaffolds for Orthopedic Tissue Repair: Challenges, Progress and Future Perspectives

Author keywords

gene activated scaffolds; non viral gene therapy; orthopedic tissue engineering; RNAi

Indexed keywords

CONTROLLED DRUG DELIVERY; DEFECTS; GENE EXPRESSION; GENE THERAPY; NUCLEIC ACIDS; PROTEINS; TARGETED DRUG DELIVERY; TISSUE; TISSUE REGENERATION;

EID: 84978869356     PISSN: 09359648     EISSN: 15214095     Source Type: Journal    
DOI: 10.1002/adma.201505088     Document Type: Article
Times cited : (96)

References (285)
  • 118
    • 84944520222 scopus 로고    scopus 로고
    • Moderna's $450-Million Venture Round
    • in, p
    • A. Mullard, Moderna's $450-Million Venture Round, in Nat. Biotechnol. 2015, p. 119–119.
    • (2015) Nat. Biotechnol. , pp. 119
    • Mullard, A.1
  • 127
    • 84978804928 scopus 로고    scopus 로고
    • D. P. Bartel, Cell 2004, 116, 2.
    • (2004) Cell , vol.116 , pp. 2
    • Bartel, D.P.1
  • 186
    • 84875865853 scopus 로고    scopus 로고
    • J. P. Behr, Chimia 1997, 51, 1–2.
    • (1997) Chimia , vol.51 , pp. 1-2
    • Behr, J.P.1
  • 280
    • 84978798691 scopus 로고    scopus 로고
    • BCC Research, Tissue Engineering, Regeneration: Technologies, Global Markets
    • (accessed: May 2015)
    • BCC Research, Tissue Engineering, Regeneration: Technologies, Global Markets, www.bccresearch.com/market-research/healthcare/tissue-engineering-regeneration-report-hlc101b.html (accessed: May 2015).
    • (2015) Tissue Engineering
    • Research, B.C.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.